University of Wisconsin researchers and collaborators recently published a feasibility study that focuses on limiting fetal growth restriction in nonhuman primates through nanoparticle injections of ...

Researchers developed an epigenetic editing approach to silence the PCSK9 gene, achieving long-term cholesterol reduction ...

The candidate in question is VY9323, an AAV gene therapy combining a highly potent pri-miRNA against superoxide dismutase 1 ...

Voyager Therapeutics (VYGR) has decided to assess alternate payloads related to its gene therapy program for superoxide dismutase 1 amyotrophic ...

New three-month data from a study of non-human primates underpins the biotech firm's decision to amend the small interfering RNA program.

Some great apes realize when a human partner doesn’t know something and are capable of communicating information to them to ...

Company to assess alternate payloads; no changes planned to novel capsid component - - Resulting shift of timeline and costs extends cash ...

Voyager Therapeutics said it will assess alternate payloads related to its gene therapeutic program related to a form of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.

Innovative muscle patches derived from stem cells demonstrate efficacy in heart repair, improving function in primates and a ...